Akèy › Myozit › Texas › Houston

Etid klinik pou Myozit nan Houston, TX

5 etid pou Myozit ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

Ap rekriteFaz 2/3

Houston Methodist Hospital - Accepting Adult Patients, Houston
University of Texas MD Anderson Cancer Center - Accepting Adult Patients, Houston

Laj 6 a 75 · Tout sèks · Mizajou Sep 17, 2026 · NCT06154252

Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy

Ap rekriteFaz 2

University of Texas - Houston, Houston

Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07103746

A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

Ap rekriteFaz 3

Nerve & Muscle Center of Texas, Houston

Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT05895786

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

Ap rekriteFaz 1/2

Nkarta Investigational Site, Houston

Laj 18 a 75 · Tout sèks · Mizajou Aug 7, 2026 · NCT06733935

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Ap rekriteFaz 2

Artiva Investigational Site Bellaire, Bellaire · 7 mi lwen

Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT06991114

Etid Myozit nan lòt vil

Lòt etid nan Houston

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.